NCT04178720

Brief Summary

The purpose of this clinical study is to evaluate the safety and effectiveness of an investigational soft contact lens compared to a commercially available soft contact lens when worn for daily wear and replaced monthly.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
119

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 26, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

January 28, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2020

Completed
11 months until next milestone

Results Posted

Study results publicly available

May 13, 2021

Completed
Last Updated

October 19, 2021

Status Verified

September 1, 2021

Enrollment Period

4 months

First QC Date

November 25, 2019

Results QC Date

April 22, 2021

Last Update Submit

September 29, 2021

Conditions

Keywords

Contact LensDaily WearVision Correction

Outcome Measures

Primary Outcomes (2)

  • Distance VA (logMAR) With Study Lenses - Completed Eyes

    Visual acuity (VA) was assessed for each eye individually with study lenses in place at a distance of 6 meters using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.

    Dispense, Week 1 follow-up, Week 2 follow-up, Month 1 follow-up, Month 2 follow-up, Month 3 follow-up (at least 4 hours after lens insertion at each follow-up assessment visit)

  • Distance VA (logMAR) With Study Lenses - Discontinued Eyes

    Visual acuity (VA) was assessed for each eye individually with study lenses in place at a distance of 6 meters using a letter chart. VA was collected in Snellen and converted to logarithm minimum angle of resolution (logMAR). A logMAR value of 0 equates to 20/20 Snellen visual acuity (normal distance eyesight), with a lower logMAR value indicating better visual acuity. No formal hypothesis testing was planned.

    Dispense, Week 1 follow-up, Week 2 follow-up, Month 1 follow-up

Study Arms (2)

LID018869

EXPERIMENTAL

Lehfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours only. The lenses will be removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.

Device: Lehfilcon A contact lensesDevice: CLEAR CARE

Biofinity

ACTIVE COMPARATOR

Comfilcon A contact lenses worn in both eyes at least approximately 8 hours per day and approximately 5 days per week during waking hours only. The lenses will be removed nightly for cleaning and disinfection and replaced monthly over the 3-month wear period.

Device: Comfilcon A contact lensesDevice: CLEAR CARE

Interventions

Investigational silicone hydrogel contact lenses

Also known as: LID018869
LID018869

Commercially available silicone hydrogel contact lenses

Also known as: CooperVision® BIOFINITY®, Biofinity
Biofinity

Hydrogen peroxide-based system for cleaning and disinfecting silicone hydrogel contact lenses

Also known as: CLEAR CARE® Cleaning & Disinfecting Solution
BiofinityLID018869

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Successful wear of spherical daily wear frequent replacement soft contact lenses for distance correction in both eyes during the past 3 months for a minimum of 5 days per week and 8 hours per day.
  • Manifest cylinder equal to or less than 0.75 diopter (D) in each eye.

You may not qualify if:

  • Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
  • Habitually wearing Biofinity contact lenses.
  • Monovision contact lens wearers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Alcon Investigative Site

Longwood, Florida, 32779, United States

Location

Alcon Investigative Site

Maitland, Florida, 32751, United States

Location

Alcon Investigative Site

Orlando, Florida, 32803, United States

Location

Alcon Investigative Site

Bloomington, Illinois, 61704, United States

Location

Alcon Investigative Site

Medina, Minnesota, 55340, United States

Location

Alcon Investigative Site

Granville, Ohio, 43023, United States

Location

Alcon Investigative Site

Memphis, Tennessee, 38111, United States

Location

Alcon Investigative Site

Memphis, Tennessee, 38119, United States

Location

MeSH Terms

Conditions

Refractive Errors

Condition Hierarchy (Ancestors)

Eye Diseases

Results Point of Contact

Title
CDMA Project Lead, Vision Care
Organization
Alcon Research, LLC

Study Officials

  • CDMA Project Lead, Vision Care

    Alcon Research, LLC

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2019

First Posted

November 26, 2019

Study Start

January 28, 2020

Primary Completion

June 10, 2020

Study Completion

June 10, 2020

Last Updated

October 19, 2021

Results First Posted

May 13, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations